益生菌在人類營養中的市場規模、佔有率和成長分析（按類型、應用和地區分類）—2026-2033年產業預測

預計到 2024 年，全球人類營養益生菌市場規模將達到 671.9 億美元，到 2025 年將成長至 722.3 億美元，到 2033 年將成長至 1,288.1 億美元，預測期（2026-2033 年）的複合年成長率為 7.5%。

全球益生菌市場在人類營養領域正經歷顯著成長，這主要得益於消費者對天然成分產品的日益偏好以及對預防醫學的關注度不斷提高。中國、日本和印度等主要地區對益生菌的需求特別強勁，促使主要企業加強研發力度，開發更先進的益生菌菌株。遞送機制的創新進一步提升了益生菌的功效，造福人類和動物健康。此外，受人口老化和消費者健康意識增強的推動，美國等富裕市場對含益生菌膳食補充劑的需求也呈現激增趨勢。這些趨勢預示著益生菌產業在不久的將來將保持強勁的成長動能。

推動全球益生菌市場在人類營養領域發展的因素

隨著消費者越來越重視維持健康的生活方式，天然食品日益受到消費者的青睞，全球益生菌市場也因此受到顯著影響。這種對健康和營養意識的提升，推動了益生菌產品需求的成長，因為越來越多的人將健康放在首位。隨著消化器官系統對定期攝取益生菌的各種健康益處（例如改善消化系統健康、減少卡路里攝取、增強免疫力和促進鈣吸收）的了解加深，益生菌原料市場在人們以自然方式改善健康的共同願望的驅動下，持續擴張。

限制全球人類營養益生菌市場的因素

全球益生菌市場在人類營養領域面臨許多挑戰，其中研發活動需要大量投資，包括建立實驗室、購買研究設備和招募專業人才。儘管益生菌的健康益處已得到科學檢驗，這為市場成長提供了支撐，但製造商往往難以從這些巨額前期投入中獲得令人滿意的回報。高成本會阻礙新進入者，並限制現有企業的擴張機會，從而形成扼殺創新、阻礙成長潛力的環境。因此，如何在研發支出和盈利能力之間取得平衡，仍然是這個快速成長市場中相關人員面臨的關鍵挑戰。

全球益生菌市場趨勢及其在人類營養領域的作用

全球益生菌市場在人類營養領域呈現強勁的創新和多元化趨勢，製造商紛紛在其產品線中添加各種益生菌產品形式，包括片劑、滴劑和膠囊，以滿足特定的健康需求。隨著消費者對腸道健康與整體健康之間聯繫的認知不斷提高，自有品牌和知名品牌公司都在積極推出含有專有益生菌菌株的新型配方。這一成長趨勢的驅動力源於消費者對個人化營養解決方案日益成長的需求，從而為膳食補充劑領域一個以功效和消費者選擇為優先的充滿活力的市場奠定了基礎。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 專利分析

全球益生菌在人類營養領域的市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 乳酸菌
• 雙叉桿菌
• 釀酒酵母
• 鏈球菌
• 腸球菌
• 大腸桿菌
• 芽孢桿菌

全球益生菌在人類營養領域的市場規模（按應用和複合年成長率分類）（2026-2033 年）

• 營養補充品
• 功能營養
• 運動營養
• 嬰幼兒營養產品
• 其他用途

全球益生菌在人類營養領域的市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Danone SA（France）
• Yakult Honsha Co., Ltd.（Japan）
• Nestle SA（Switzerland）
• Chr. Hansen Holding A/S（Denmark）
• International Flavors & Fragrances Inc.（IFF）（USA）
• Archer Daniels Midland Company（ADM）（USA）
• Probi AB（Sweden）
• BioGaia AB（Sweden）
• Morinaga Milk Industry Co., Ltd.（Japan）
• Lifeway Foods, Inc.（USA）
• General Mills, Inc.（USA）
• PepsiCo, Inc.（USA）
• Kerry Group plc（Ireland）
• Lallemand Inc.（Canada）
• UAS Laboratories LLC（USA）
• Winclove Probiotics BV（Netherlands）
• DSM-Firmenich（Netherlands/Switzerland）
• Sabinsa Corporation（USA）
• Protexin（UK）（part of ADM）
• Bifodan A/S（Denmark）

結論與建議

Global Probiotics In Human Nutrition Market size was valued at USD 67.19 Billion in 2024 and is poised to grow from USD 72.23 Billion in 2025 to USD 128.81 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global probiotics market in human nutrition is experiencing significant growth, driven by a rising preference for natural ingredient-based products and a heightened focus on preventive healthcare. Demand for probiotics is particularly robust in key regions, including China, Japan, and India, where major companies are intensifying research and development efforts to create advanced probiotic strains. Innovations in delivery mechanisms further enhance the effectiveness of probiotics, benefiting both human and animal health. Additionally, affluent markets, such as the United States, are witnessing a surge in the consumption of probiotic dietary supplements, spurred by an aging population and increased consumer awareness regarding health and wellness. These trends indicate a strong growth trajectory for the probiotics sector in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Probiotics In Human Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Probiotics In Human Nutrition Market Segments Analysis

Global Probiotics In Human Nutrition Market is segmented by Type, Application and region. Based on Type, the market is segmented into Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, Escherichia and Bacillus. Based on Application, the market is segmented into Dietary Supplements, Functional Nutrition,Sports Nutrition,Infant Nutritionand other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market is significantly influenced by the growing popularity of natural food products as consumers increasingly recognize the importance of maintaining a healthy lifestyle. This heightened awareness surrounding health and nutrition has sparked increased demand for probiotic offerings, with many individuals prioritizing their personal well-being. As consumers become more informed about the various health benefits associated with the regular consumption of probiotics-such as enhanced digestive health, reduced caloric intake, improved immunity, and better calcium absorption-the market for probiotic ingredients continues to expand, driven by a collective desire for enhanced health outcomes through natural means.

Restraints in the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market faces challenges stemming from significant investments required for research and development activities, which include setting up laboratories, acquiring research equipment, and recruiting skilled personnel. While scientific validation of probiotics' health benefits supports market growth, manufacturers often struggle to achieve a satisfactory return on these substantial initial expenses. These high costs can deter new entrants and limit expansion opportunities for existing businesses, creating an environment where innovation may be stifled and growth potential compromised. As a result, balancing research expenditures with profitability remains a critical concern for stakeholders in this burgeoning market.

Market Trends of the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market is witnessing a robust trend towards innovation and diversification, with manufacturers expanding their product lines to include a variety of probiotic formats such as pills, drops, and capsules tailored to specific health needs. As consumer awareness of gut health and its connection to overall wellness continues to rise, both private label and branded companies are proactively introducing novel formulations featuring distinct probiotic strains. This growth trajectory is driven by the increasing demand for personalized nutrition solutions, setting the stage for a dynamic marketplace that prioritizes efficacy and consumer choice in the realm of dietary supplementation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Probiotics In Human Nutrition Market Size by Type & CAGR (2026-2033)

• Market Overview
• Lactobacillus
• Bifidobacterium
• Saccharomyces
• Streptococcus
• Enterococcus
• Escherichia
• Bacillus

Global Probiotics In Human Nutrition Market Size by Application & CAGR (2026-2033)

• Market Overview
• Dietary Supplements
• Functional Nutrition
• Sports Nutrition
• Infant Nutrition
• Other Applications

Global Probiotics In Human Nutrition Market Size & CAGR (2026-2033)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Danone S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yakult Honsha Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chr. Hansen Holding A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Flavors & Fragrances Inc. (IFF) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company (ADM) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Probi AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGaia AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morinaga Milk Industry Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifeway Foods, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Mills, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PepsiCo, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UAS Laboratories LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Winclove Probiotics B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM-Firmenich (Netherlands/Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Protexin (UK) (part of ADM)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bifodan A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations